Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

被引:1
|
作者
Simpson, Eric L. [1 ]
Silverberg, Jonathan, I [2 ]
Worm, Margitta [3 ]
Honari, Golara [4 ]
Masuda, Koji [5 ]
Sygula, Ewa [6 ]
Maloney, Jennifer [7 ]
Mannent, Leda P. [8 ]
Xiao, Jing [7 ]
Dubost-Brama, Ariane [8 ]
Bansal, Ashish [7 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] George Washington Sch Med & Hlth Sci, Washington, DC USA
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Stanford Univ, Sch Med, Redwood City, CA USA
[5] Kyoto Prefectural Univ Med, Kyoto, Japan
[6] Andrzej Mielecki Mem Independent Publ Clin Hosp, Katowice, Poland
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Chilly Mazarin, France
关键词
dupilumab; moderate-to-severe; hand; foot; dermatitis;
D O I
10.1093/bjd/ljad162.029
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
408
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial
    Yang, Hyeon-Jong
    Min, Taek Ki
    Lee, Hae Won
    Pyun, Bok Yang
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2014, 6 (03) : 208 - 215
  • [22] Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase3trial
    Cadot, Pierre
    Hensel, Patrick
    Bensignor, Emmanuel
    Hadjaje, Celine
    Marignac, Genevieve
    Beco, Luc
    Fontaine, Jacques
    Jamet, Jean-Francois
    Georgescu, Gabriela
    Campbell, Karen
    Cannon, Andrea
    Osborn, Sarah C.
    Messinger, Linda
    Gogny-Goubert, Michel
    Dubreuil, Patrice
    Moussy, Alain
    Hermine, Olivier
    VETERINARY DERMATOLOGY, 2011, 22 (06) : 554 - 564
  • [23] The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study
    Zhao, Y.
    Wu, L.
    Lu, Q.
    Gao, X.
    Zhu, X.
    Yao, X.
    Li, L.
    Li, W.
    Ding, Y.
    Song, Z.
    Liu, L.
    Dang, N.
    Zhang, C.
    Liu, X.
    Gu, J.
    Wang, J.
    Geng, S.
    Liu, Q.
    Guo, Y.
    Dong, L.
    Su, H.
    Bai, L.
    O'Malley, J. T.
    Luo, J.
    Laws, E.
    Mannent, L.
    Ruddy, M.
    Amin, N.
    Bansal, A.
    Ota, T.
    Wang, M.
    Zhang, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 633 - 641
  • [24] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Zhao, Yan
    Wu, Liming
    Lu, Qianjin
    Gao, Xinghua
    Zhu, Xiaohong
    Yao, Xu
    Li, Linfeng
    Li, Wei
    Ding, Yangfeng
    Song, Zhiqiang
    Liu, Lingling
    Dang, Ningning
    Zhang, Chunlei
    Liu, Xiaoming
    Gu, Jun
    Wang, Jinyan
    Geng, Songhai
    Liu, Qunazhong
    Guo, Yifeng
    Lv, Dong
    Ren, Gong
    Yang, Xiumin
    Deng, Danqi
    Li, Shanshan
    Han, Xiuping
    Biao, Shuzhen
    Zheng, Min
    Dong, Li
    Su, Huijuan
    Bai, Lili
    O'Malley, John T.
    Luo, Junxiang
    Zhang, Jianzhong
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
  • [25] Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
    Yosipovitch, Gil
    Mollanazar, Nicholas
    Staender, Sonja
    Kwatra, Shawn G.
    Kim, Brian S.
    Laws, Elizabeth
    Mannent, Leda P.
    Amin, Nikhil
    Akinlade, Bolanle
    Staudinger, Heribert W.
    Patel, Naimish
    Yancopoulos, George D.
    Weinreich, David M.
    Wang, Sheldon
    Shi, Genming
    Bansal, Ashish
    O'Malley, John T.
    NATURE MEDICINE, 2023, 29 (05) : 1180 - +
  • [26] Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
    Gil Yosipovitch
    Nicholas Mollanazar
    Sonja Ständer
    Shawn G. Kwatra
    Brian S. Kim
    Elizabeth Laws
    Leda P. Mannent
    Nikhil Amin
    Bolanle Akinlade
    Heribert W. Staudinger
    Naimish Patel
    George D. Yancopoulos
    David M. Weinreich
    Sheldon Wang
    Genming Shi
    Ashish Bansal
    John T. O’Malley
    Nature Medicine, 2023, 29 : 1180 - 1190
  • [27] The effect of dupilumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial
    Blauvelt, A.
    Simpson, E.
    Wu, R.
    Akinlade, B.
    Graham, N.
    Pirozzi, G.
    Evans, R.
    ALLERGY, 2016, 71 : 95 - 95
  • [28] Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial
    Viljanen, M
    Savilahti, E
    Haahtela, T
    Juntunen-Backman, K
    Korpela, R
    Poussa, T
    Tuure, T
    Kuitunen, M
    ALLERGY, 2005, 60 (04) : 494 - 500
  • [29] POLYPODIUM LEUCOTOMOS EXTRACT IN ATOPIC DERMATITIS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND MULTICENTER CLINICAL TRIAL
    Ramirez-Bosca, A.
    Zapater Hernandez, P.
    Betlloch, I
    Albero, F.
    Martinez, A.
    De la Parte, Horga J. F.
    Diaz Alperi, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 28 - 28
  • [30] Efficacy of Individualized Homeopathic Medicines in the Treatment of Atopic Dermatitis in Adults: A Double-Blind, Randomized, Placebo-Controlled, Preliminary Trial
    Dey, Samit
    Shaikh, Abdur Rahaman
    Saha, Sangita
    Agrawal, Ekta
    Gautam, Ashish Kumar
    Karuppusamy, Avaranjika
    Sadhukhan, Satarupa
    Dutta, Souvik
    Ali, Sk. Swaif
    Basu, Anamika
    Koley, Munmun
    Saha, Subhranil
    COMPLEMENTARY MEDICINE RESEARCH, 2022, 29 (01) : 17 - 26